Found 6 matching trials
Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer PHASE1 RATIONALE: Radiation therapy uses high-energy x-rays and other sources to d...
Show More Location
Yale Comprehensive Cancer Center
Learn More & Join Trial
Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors PHASE4 The objective of this study was to evaluate the effect of age (geriatric) a...
Show More Location
University of Miami, Jackson Memorial Hospital
Learn More & Join Trial
Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors PHASE2 The purpose of this study is to determine if High-dose 111In-Pentetreotide ...
Show More Location
Excel Diagnostic Imaging Clinics
Learn More & Join Trial
Combination Targeted Radiotherapy in Neuroendocrine Tumors NA The primary aim of this project is to determine, what fraction of individua...
Show More Location
University of Iowa
Learn More & Join Trial
Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT PHASE2 This clinical trial studies gallium Ga 68-edotreotide positron emission tom...
Show More Location
University of Iowa Hospitals and Clinics
Learn More & Join Trial
Metabolic Radiotherapy After Complete Resection of Liver Metastases in Patient With Digestive Neuroendocrine Tumor PHASE3 TERAVECT is a phase III randomized study of patients with digestive neuroen...
Show More Location
Hôpital Haut Lévêque - CHU Bordeaux
Learn More & Join Trial